Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.273ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.273ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.273ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.273NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.4.13 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.13 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.13 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.13 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.358ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.358ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.358ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.358NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.60ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.60ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.60NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.159ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.159ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.159ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.159NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.510ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.510ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.510ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.510NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.91ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.91ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.91ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.91NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.227ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.227ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.227ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.227NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.555ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.555ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.555ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.555NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.513ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.513ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.513ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used